samyounglab retweeted
Delighted to share our new Nature paper: rdcu.be/dNlMQ
This works shows a surprising off-target effect of glutamate on another cell death channel, acid sensing ion channels (ASICs). It turns out that glutamate directly binds to ASICs as a positive allosteric modulator
Amazing findings !!
Congrats you and the team
Delighted to share our new Nature paper: rdcu.be/dNlMQ
This works shows a surprising off-target effect of glutamate on another cell death channel, acid sensing ion channels (ASICs). It turns out that glutamate directly binds to ASICs as a positive allosteric modulator
samyounglab retweeted
So for those of you interested in what it was that I took issue with in Hubermans first cannabis podcast, this is the Coles notes of the errors/inaccuracies that I noted. A lot of this is covered in the new episode, but some wont make it through and for others this is the TLDR
New Huberman Lab podcast out now:
CANNABIS: EFFECTS ON HEALTH & RISKS w/guest @canna_brain
•THC, CBD Biology
•Cannabis & Psychosis
•Is THC addictive?
•Are Strain Differences Real or Placebo?
•Appetite, Hormones
•Dosage Control: Inhaled vs Edible
hubermanlab.com/episode/dr-m…
Love cellular and molecular neuro. We are hiring a staff scientist interested in building framework of molecular principles for accurate sound information encoding and contribution to auditory deficits.
unc.peopleadmin.com/hr/posti…
Must have background in patch clamp
DM or email
Big news. We are moving.
I have officially started as the Director of the Gene Therapy Center, and as a Professor of Pediatrics and Professor of Pharmacology at UNC-Chapel Hill. I am returning “home” to lead the Center where I earned my PhD.
Amazing paper!!! Congratulations to you and John and the team.
Check it out: most beautiful images of vATPase with a surprising partner on live synaptic vesicles from my brilliant colleague John Rubinstein and his team at SickKids Reaearch Institute & University of Toronto!
science.org/doi/10.1126/scie…
I will always treasure my time in the Department and at the U. Amazing colleagues and research environment. It is extremely difficult to say goodbye. Once a Hawkeye always a Hawkeye.
Don't forget @JPhysiol
Replying to @Wessel_Lab
Lift heavy weight
Squats deadlifts and bench press
Replying to @cacna1a
Thankyou for all your support in making this research happen!
Finally, I want to thank Dr. Emre Kul, Uchechi Okorafor @MissSafie and the rest of the team for taking on this immense challenge to solve a fundamental problem in the gene therapy field.
We thank @FamilieSCN2A @scn2agene @cacna1a @ncats_nih_gov @NIH_NINDS @NIDCD @uihealthcare @uiowaOUR funding this research We thank @UIowaACB @UIowaNeuro @UIowaResearch for creating an amazing environment for carrying out high risk high reward research
Since Ad vector transduction properties are dependent on their capsid proteins, these chimeric 1st generation Ad vectors open new avenues for high capacity helper-dependent adenovirus (HdAd) gene therapy approaches for cerebellar disorders and multiple neurological disorders.
Using a “humanized” hCD46 mouse model, we demonstrate these Ad vectors transduce cerebellar cell-types, including Purkinje cells, that are refractory to Ad5 transduction.
Therefore, to overcome the current limitations of Ad vectors to treat CNS disorders, we created chimeric 1st generation Ad vectors that utilize the hCD46 receptor.




